Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, Netherlands.
Nat Rev Urol. 2023 Nov;20(11):669-681. doi: 10.1038/s41585-023-00781-8. Epub 2023 Jun 16.
Renal cell carcinoma (RCC) incidence has doubled over the past few decades. However, death rates have remained stable as the number of incidental renal mass diagnoses peaked. RCC has been recognized as a European health care issue, but to date, no screening programmes have been introduced. Well-known modifiable risk factors for RCC are smoking, obesity and hypertension. A direct association between cigarette consumption and increased RCC incidence and RCC-related death has been reported, but the underlying mechanistic pathways for this association are still unclear. Obesity is associated with an increased risk of RCC, but interestingly, improved survival outcomes have been reported in obese patients, a phenomenon known as the obesity paradox. Data on the association between other modifiable risk factors such as diet, dyslipidaemia and physical activity with RCC incidence are conflicting, and potential mechanisms underlying these associations remain to be elucidated.
过去几十年间,肾细胞癌(RCC)的发病率翻了一番。然而,随着偶然发现的肾肿块诊断数量达到峰值,死亡率保持稳定。RCC 已被视为欧洲的医疗保健问题,但迄今为止,尚未引入任何筛查计划。众所周知的 RCC 可改变的风险因素包括吸烟、肥胖和高血压。已经有报道称,吸烟与 RCC 发病率和与 RCC 相关的死亡率增加之间存在直接关联,但这种关联的潜在机制途径仍不清楚。肥胖与 RCC 风险增加有关,但有趣的是,肥胖患者的生存结果得到了改善,这种现象被称为肥胖悖论。关于其他可改变的风险因素(如饮食、血脂异常和体力活动)与 RCC 发病率之间关联的数据相互矛盾,这些关联的潜在机制仍有待阐明。